We are live on ! Find out more
JFG

Jefferies Financial Group Portfolio holdings

AUM $15.2B
1-Year Est. Return 55.75%
This Fund
S&P 500
This Quarter Est. Return
+8.3%
1 Year Est. Return
+55.75%
3 Year Est. Return
+134.64%
5 Year Est. Return
+55.21%
10 Year Est. Return
+628.45%
AUM
$19.6B
AUM Growth
-$1.62B
Cap. Flow
+$694M
Cap. Flow %
3.55%
Top 10 Hldgs %
28.04%
Holding
2,127
New
700
Increased
505
Reduced
388
Closed
303

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$316M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$222M
3
AMZN icon
Amazon
AMZN
+$152M
4
INSM icon
Insmed
INSM
+$149M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$126M

Top Sells

Rank Stock Value
1
VGT icon
Vanguard Information Technology ETF
VGT
+$1.68B
2
WRB icon
W.R. Berkley
WRB
+$683M
3
LLY icon
Eli Lilly
LLY
+$229M
4
COST icon
Costco
COST
+$188M
5
PEP icon
PepsiCo
PEP
+$136M

Sector Composition

Rank Sector Weight
1 Miscellaneous 52.36%
2 Healthcare 10.49%
3 Technology 8.24%
4 Financials 7%
5 Industrials 4.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRBU icon
1626
Caribou Biosciences
CRBU
$133M
$71.3K ﹤0.01%
44,840
-2,360
-5% -$4.95K
CAMP icon
1627
CAMP4 Therapeutics
CAMP
$246M
$69.6K ﹤0.01%
+11,361
New +$48.3K
GALT icon
1628
Galectin Therapeutics
GALT
$393M
$68.4K ﹤0.01%
16,435
-865
-5% -$4.55K
ASST icon
1629
CALL
Strive Inc
ASST
$2.86B
$68.3K ﹤0.01%
4,625
+820
+22% +$19.6K
BLNK icon
1630
Blink Charging
BLNK
$84M
$67.5K ﹤0.01%
101,219
+1,219
+1% +$1.76K
CCCC icon
1631
C4 Therapeutics
CCCC
$367M
$67.5K ﹤0.01%
35,340
-2,860
-7% -$6.78K
ASST icon
1632
Strive Inc
ASST
$2.86B
$66.4K ﹤0.01%
4,500
+4,070
+947% +$97.2K
VOYG
1633
Voyager Technologies
VOYG
$1.91B
$62.7K ﹤0.01%
+2,400
New +$65.1K
EXAS
1634
CALL
DELISTED
Exact Sciences
EXAS
$60.9K ﹤0.01%
+600
New +$48.2K
NU icon
1635
Nu Holdings
NU
$65.6B
$60.1K ﹤0.01%
3,591
-217,793
-98% -$3.5M
HTGC icon
1636
Hercules Capital
HTGC
$3.18B
$56K ﹤0.01%
2,977
+1,585
+114% +$28.6K
MRVI icon
1637
Maravai LifeSciences
MRVI
$1.13B
$55.3K ﹤0.01%
17,000
– –
BTG icon
1638
B2Gold
BTG
$7.24B
$54.7K ﹤0.01%
+12,135
New +$56.6K
BDTX icon
1639
Black Diamond Therapeutics
BDTX
$108M
$52.6K ﹤0.01%
21,660
-1,140
-5% -$4.04K
RIVN icon
1640
Rivian
RIVN
$22.4B
$52.6K ﹤0.01%
+2,670
New +$42.4K
PRCH icon
1641
Porch Group
PRCH
$1.88B
$51.5K ﹤0.01%
+5,640
New +$67.9K
GNLX icon
1642
Genelux
GNLX
$112M
$47.7K ﹤0.01%
+10,940
New +$59.1K
INDI icon
1643
indie Semiconductor
INDI
$700M
$47.3K ﹤0.01%
13,396
– –
CSGP icon
1644
PUT
CoStar Group
CSGP
$11.4B
$47.1K ﹤0.01%
+700
New +$49.6K
FLNC icon
1645
Fluence Energy
FLNC
$1.12B
$45.7K ﹤0.01%
+2,312
New +$43.6K
GDC icon
1646
GD Culture Group
GDC
$5.66M
$44.4K ﹤0.01%
+42
New +$47.5K
ZBRA icon
1647
Zebra Technologies
ZBRA
$17.5B
$44K ﹤0.01%
+181
New +$48.4K
TNYA icon
1648
Tenaya Therapeutics
TNYA
$137M
$41.4K ﹤0.01%
58,235
-3,065
-5% -$4.17K
GME.WS
1649
GameStop Corp Warrants
GME.WS
$40.7K ﹤0.01%
+13,518
New +$41.9K
RANI icon
1650
Rani Therapeutics
RANI
$87.6M
$40.3K ﹤0.01%
+29,870
New +$45.1K
64 65
66
67 68

Similar funds

IFP
Independent Franchise Partners London, United Kingdom $15.2B AUM 1.56% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $15.3B AUM 24.71% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $15.3B AUM 25.33% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
VIM
Vinva Investment Management Sydney, Australia $15.1B AUM 39.47% 1-Year Est. Return

Jefferies Financial Group's Q4 2025 Portfolio in Review

As of Q4 2025, Jefferies Financial Group held 2,127 positions worth $19.6B, down 7.6% from $21.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Jefferies Financial Group deployed $694M of net new capital in Q4 2025, opening 700 new positions and adding to 505 existing holdings. Its largest new stake was Roivant Sciences: 3,514,833 shares worth $76.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, down from 68% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Eli Lilly, an estimated $229M trimmed.

  • Jefferies Financial Group's largest Q4 2025 buy was Roivant Sciences: 3,514,833 shares worth $76.3M.
  • Jefferies Financial Group added most to NVIDIA in Q4 2025, an estimated $316M increase.
  • Jefferies Financial Group's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $229M.
  • Jefferies Financial Group fully exited Vanguard Information Technology ETF in Q4 2025, selling an estimated $1.68B.
  • Jefferies Financial Group's ten largest holdings make up 28% of its $19.6B portfolio in Q4 2025.
  • Jefferies Financial Group opened 700 new positions and closed 303 in Q4 2025.
  • Jefferies Financial Group's portfolio value fell 7.6% quarter-over-quarter to $19.6B.

Based on Jefferies Financial Group's 13F filing for Q4 2025, filed 9 Feb 2026.